08:00 , Jan 5, 2009 |  BC Week In Review  |  Clinical News

Healive regulatory update

Sinovac said an autopsy revealed that a previously reported death of a child in China was caused by myocarditis and not related to administration of the company's Healive inactivated hepatitis A vaccine. In November, China's...
08:00 , Dec 8, 2008 |  BC Week In Review  |  Clinical News

Healive regulatory update

Sinovac said the Health Services Bureau of Fengtai District in Beijing suspended the use of Healive following the death of a child who had received the inactivated hepatitis A vaccine 2 days earlier. The company...
07:00 , Sep 22, 2008 |  BC Week In Review  |  Clinical News

Healive: Pivotal trial started

Biolik began a Ukranian pivotal trial of Healive in 300 adults and 200 children. The company licensed rights for Healive in the Commonwealth of Independent States from Sinovac, which markets the vaccine in China. Sinovac...